Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Terabe Website

Masaki Terabe, Ph.D.

Selected Publications

1)  Terabe M, Berzofsky JA.
The immunoregulatory role of type I and type II NKT cells in cancer and other diseases.
Cancer Immunol. Immunother. 63: 199-213, 2014.
2)  Izhak L, Berzofsky JA, Terabe M.
Balance is a key for happiness.
Oncoimmunology. 2: e24211, 2013.
3)  Berzofsky JA, Wood LV, Terabe M.
Cancer vaccines: 21st century approaches to harnessing an ancient modality to fight cancer.
Expert Rev Vaccines. 12: 1115-8, 2013.
4)  Izhak L, Ambrosino E, Kato S, Parish ST, O'Konek JJ, Weber H, Xia Z, Venzon D, Berzofsky JA, Terabe M.
Delicate balance among three types of T cells in concurrent regulation of tumor immunity.
Cancer Res. 73: 1514-23, 2013.
5)  Huang YH, Terabe M, Pendleton CD, Stewart Khursigara D, Bera TK, Pastan I, Berzofsky JA.
Identification and enhancement of HLA-A2.1-restricted CTL epitopes in a new human cancer antigen-POTE.
PLoS ONE. 8: e64365, 2013.
6)  O'Konek JJ, Kato S, Takao S, Izhak L, Xia Z, Illarionov P, Besra GS, Terabe M, Berzofsky JA.
ß-Mannosylceramide Activates Type I Natural Killer T Cells to Induce Tumor Immunity without Inducing Long-Term Functional Anergy.
Clin. Cancer Res. 19: 4404-11, 2013.
7)  Berzofsky JA, Terabe M, Wood LV.
Strategies to use immune modulators in therapeutic vaccines against cancer.
Semin. Oncol. 39: 348-57, 2012.
8)  Nakashima H, Terabe M, Berzofsky JA, Husain SR, Puri RK.
A novel combination immunotherapy for cancer by IL-13Ra2-targeted DNA vaccine and immunotoxin in murine tumor models.
J. Immunol. 187: 4935-46, 2011.
9)  Yu H, Tawab-Amiri A, Dzutsev A, Sabatino M, Aleman K, Yarchoan R, Terabe M, Sui Y, Berzofsky JA.
IL-15 ex vivo overcomes CD4+ T cell deficiency for the induction of human antigen-specific CD8+ T cell responses.
J. Leukoc. Biol. 90: 205-14, 2011.
10)  Lai D, Zhu J, Wang T, Hu-Li J, Terabe M, Berzofsky JA, Clayberger C, Krensky AM.
KLF13 sustains thymic memory-like CD8(+) T cells in BALB/c mice by regulating IL-4-generating invariant natural killer T cells.
J. Exp. Med. 208: 1093-103, 2011.
Click Here to View Expanded Bibliography.

This page was last updated on 4/15/2014.